ClinicalTrials.govpublic full text
Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio
bile duct cancer, cholangiocarcinoma, cholangiocarcinoma non-resectable, cholangiocarcinoma metastatic, metastatic intrahepatic cholangiocarcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 811172
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.